Robert S. Gaston - Concepedia

Author

Robert S. Gaston

University of Alabama at Birmingham ORCID

Also Known As

Cathy Garvey, Fernando G. Cosio, Gaston, Robert, R Gaston, R S Gaston, R. Gaston, R. S. Gaston, R.S Gaston, R.S. Gaston, ROBERT S. GASTON

215

Publications

12K

Citations

H-Index

110

Concepts

All Affiliations

University of Alabama at Birmingham University of Minnesota Hennepin County Medical Center University of Iowa University of Manitoba

About

Robert S. Gaston is an author at University of Alabama at Birmingham specializing in medicine, kidney transplant, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	33	44	4K
2	Public Health	6	6	877
3	African American Studies	3	3	193
4	Education	2	2	64
5	Nursing	1	1	13

Robert S. Gaston

Publications

9.1K

Citations

H-Index

Page 1

	Year	Citations
Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation F. Vincenti, Robert L. Kirkman, Susan Light, New England Journal of Medicine	1998	875
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients Bertram L. Kasiske, Miguel A. Vazquez, William Harmon, Journal of the American Society of Nephrology Transplantation SurgeryRenal CareUrologyTransplantationKidney Transplant	2000	628
Kidney Transplantation as Primary Therapy for End-Stage Renal Disease Michaël Abécassis, Stephen T. Bartlett, Allan J. Collins, Clinical Journal of the American Society of Nephrology	2008	586
Report of a National Conference on Donation after Cardiac Death James L. Bernat, Anthony M. D’Alessandro, F K Port, American Journal of Transplantation Organ DonationHeart FailureNational ConferenceOrgan ProcurementCardiopulmonary Resuscitation	2006	502
Evidence for Antibody-Mediated Injury as a Major Determinant of Late Kidney Allograft Failure Robert S. Gaston, J. Michael Cecka, Bert L Kasiske, Transplantation	2010	478
RESULTS OF THE DOUBLE-BLIND, RANDOMIZED, MULTICENTER, PHASE III CLINICAL TRIAL OF THYMOGLOBULIN VERSUS ATGAM IN THE TREATMENT OF ACUTE GRAFT REJECTION EPISODES AFTER RENAL TRANSPLANTATION1,2 A. Osama Gaber, M. Roy First, Raymond J. Tesi, Transplantation	1998	299
EVALUATION OF LIVING RENAL DONORS THE CURRENT PRACTICE OF US TRANSPLANT CENTERS Margaret J. Bia, Eleanor L. Ramos, Gabriel M. Danovitch, Transplantation	1995	252
Inflammation in Areas of Tubular Atrophy in Kidney Allograft Biopsies: A Potent Predictor of Allograft Failure Roslyn B. Mannon, Arthur J. Matas, Joseph P. Grande, American Journal of Transplantation	2010	223
Fixed- or Controlled-Dose Mycophenolate Mofetil with Standard- or Reduced-Dose Calcineurin Inhibitors: The Opticept Trial Robert S. Gaston, Bruce Kaplan, T. Shah, American Journal of Transplantation Molecular PharmacologyControlled-dose Mycophenolate MofetilTherapeutic Drug MonitoringOphthalmologyReduced-dose Calcineurin Inhibitors	2009	187
The APOL1 Genotype of African American Kidney Transplant Recipients Does Not Impact 5-Year Allograft Survival B.T Lee, Vineeta Kumar, Tom A. Williams, American Journal of Transplantation	2012	180

Page 1